Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, announces the launch of its latest core technology — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results